Publications by authors named "A Carnevali"
Background/objective: Retinal vein occlusion (RVO) is a common, sight-threatening vascular disorder affecting individuals of all ages, with incidence increasing with age. Due to its complex, multifactorial nature, treating RVO remains a clinical challenge. Currently, treatment strategies include laser photocoagulation (especially for branch RVO), anti-VEGF therapies, and intravitreal corticosteroids.
View Article and Find Full Text PDFBackground: Patient expectations play a crucial role in aesthetic treatments, influencing satisfaction of treatment outcomes.
Objective: To explore and assess the expectations of 102 participants undergoing various cosmetic interventions using the FACE-Q expectations scale.
Materials And Methods: Participants, aged 20 to 64 years, seeking different facial aesthetic procedures completed the FACE-Q expectations scale before treatment.
Article Synopsis
- The study compares structural optical coherence tomography (OCT) and infrared reflectance (IR) imaging to analyze differences in non-exudative macular neovascularizations (NE MNVs) caused by age-related macular degeneration (AMD) and those linked to the pachychoroid spectrum.
- It assessed patients with documented NE-MNVs, focusing on treatment-naïve cases that remained non-exudative for at least a year and had high-quality imaging available.
- Results indicated that NE-MNVs in pachychoroid eyes exhibited sharper, more inhomogeneous pigment epithelium detachments and were more likely to show a hyporeflective halo than those in AMD eyes.
Despite recent advances, pharmacological treatments of diabetic retinopathy (DR) do not directly address the underlying oxidative stress. This study evaluates the efficacy of a nutraceutical formulation based on maltodextrinated grape pomace extract (MaGPE), an oxidative stress inhibitor, in managing DR. A 6-month, randomized, placebo-controlled clinical trial involving 99 patients with mild to moderate non-proliferative DR was conducted.
View Article and Find Full Text PDFArticle Synopsis
- Photobiomodulation (PBM) is a new technique using light to potentially slow down early and intermediate dry age-related macular degeneration (dAMD) and is being analyzed for its safety and effectiveness with the EYE-LIGHT device.
- The study involved patients over 50 with dAMD, randomly assigned to either PBM treatment or a sham procedure, with assessments conducted after four weeks.
- Results showed that PBM treatment was generally well-tolerated, with improved visual acuity for some patients, though no significant differences in central subfield thickness were observed.